Yale New Haven Hospital
Yale New Haven Hospital was paid $629K by Medicaid between Jan 2018 and Oct 2024, across 80 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
NEW HAVEN, CT 06504
Next to other General Acute Care Hospital providers in Connecticut
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,647 | $96K | |
| 2019 | 10,407 | $70K | |
| 2020 | 16,858 | $139K | |
| 2021 | 16,945 | $195K | |
| 2022 | 13,696 | $118K | |
| 2023 | 5,624 | $11K | |
| 2024incomplete | 2,295 | $2K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 783 | 735 | $108K |
| 80048 | Basic metabolic panel (calcium, ionized) | 16% | 10,601 | 2,295 | $100K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 674 | 627 | $98K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 1,455 | 1,075 | $77K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.8% | 289 | 257 | $43K |
| G0378 | Hospital observation service, per hour | 4.8% | 14 | 14 | $30K |
| 36415 | Collection of venous blood by venipuncture | 3.8% | 3,420 | 1,190 | $24K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.5% | 277 | 215 | $16K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 956 | 918 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.9% | 1,098 | 811 | $12K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.8% | 2,734 | 860 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 10,953 | 3,143 | $8K |
68 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 40 | $8K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 1,314 | $8K |
| 80053 | Comprehensive metabolic panel | 1.2% | 3,685 | $7K |
| 83735 | <1% | 6,994 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 46 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 141 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 858 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,219 | $3K |
| 82248 | <1% | 1,841 | $3K | |
| 0001A | <1% | 96 | $3K | |
| 81001 | <1% | 980 | $3K | |
| 82803 | <1% | 1,418 | $3K | |
| 0002A | <1% | 92 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 111 | $2K |
| 84484 | <1% | 1,860 | $2K | |
| 84100 | <1% | 4,108 | $2K | |
| 99442 | <1% | 165 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 422 | $2K |
| 86850 | <1% | 719 | $1K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $1K |
| 86901 | <1% | 747 | $1K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $1K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 83 | $1K |
| 82247 | <1% | 348 | $923.10 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 124 | $766.19 |
| 86900 | <1% | 747 | $714.21 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 28 | $710.38 |
| 83605 | <1% | 1,341 | $578.03 | |
| 82374 | <1% | 660 | $556.76 | |
| 85027 | <1% | 2,063 | $547.20 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 17 | $545.04 |
| 82565 | <1% | 721 | $489.77 | |
| 81025 | <1% | 49 | $454.20 | |
| J3490 | Unclassified drugs | <1% | 105 | $396.04 |
| 83690 | <1% | 444 | $391.77 | |
| 82947 | <1% | 778 | $372.25 | |
| 84295 | <1% | 773 | $334.02 | |
| 84520 | <1% | 710 | $326.04 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 30 | $285.20 |
| 85610 | <1% | 2,955 | $248.27 | |
| 84132 | <1% | 567 | $242.88 | |
| 83880 | <1% | 144 | $178.92 | |
| 82330 | <1% | 224 | $166.34 | |
| 87040 | <1% | 357 | $153.37 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 406 | $129.90 |
| 84460 | <1% | 308 | $128.16 | |
| 82310 | <1% | 90 | $126.94 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 244 | $120.45 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15 | $97.00 |
| 85014 | <1% | 333 | $95.96 | |
| 84075 | <1% | 310 | $95.34 | |
| 84450 | <1% | 251 | $94.84 | |
| 84145 | <1% | 420 | $94.63 | |
| 97162 | <1% | 72 | $81.81 | |
| 85730 | <1% | 1,476 | $70.83 | |
| 82435 | <1% | 120 | $49.22 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 99 | $28.40 |
| 81003 | <1% | 61 | $23.58 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $12.69 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 16 | $5.99 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 479 | $0.18 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 65 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 65 | $0.00 |
| 91300 | 0% | 140 | $0.00 | |
| 87186 | 0% | 17 | $0.00 | |
| 97116 | 0% | 35 | $0.00 | |
| 87205 | 0% | 19 | $0.00 | |
| 87070 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Yale New Haven Hospital | New Haven, CT | $1.08B |
| Bridgeport Hospital | Bridgeport, CT | $287.34M |
| Lawrence and Memorial Hospital, INC. | New London, CT | $136.19M |
| Greenwich Hospital | Greenwich, CT | $46.42M |
| Bridgeport Hospital | Milford, CT | $15.60M |
| LMW Healthcare INC. | Westerly, RI | $13.10M |
| Lawrence and Memorial Hospital, INC. | New London, CT | $1.55M |
| LMW Healthcare INC. | Westerly, RI | $492K |
| Bridgeport Hospital | Bridgeport, CT | $398K |
| Lawrence and Memorial Hospital, INC. | New London, CT | $365K |
| Shoreline Endoscopy Center, LLC | Guilford, CT | $19K |
| Yale New Haven Hospital | New Haven, CT | $860.83 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.